Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Martin Mikkelsen
    Member
    • Jun 2010
    • 11

    #1

    Help on library, restriction enzyme fragmentation

    Dear Everyone,

    At our lab we are doing a sequencing project sequencing a short gene (1500 kb) in humans. The length of the amplicon does not really fit any of the fragmentations tools available in our lab, so we decided to cut the DNA using restrictions enzymes instead. However, when building our library using the standard Rapid Library protocol (NEB or Roche kits) all our DNA seems to disappear somewhere between the end repair and the ligation. The restrictions enzymes creates a mix of blunt end and overlapping end.

    We are running out of ideas....
    - Should we just try to ligate the adaptors on without any end repair?
    - Should we leave out any of the enzymes?

    Any thoughts on the above or help would be very much appreciated.

    Martin
  • flxlex
    Moderator
    • Nov 2008
    • 412

    #2
    Have you considered PacBio sequencing instead? No need to fragment the 1500 bp product, high quality reads (circular consensus) and 1500 bp should now be possible.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
      by SEQadmin2




      NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
      Today, 06:46 AM
    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-28-2026, 09:57 AM
    0 responses
    22 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-28-2026, 09:51 AM
    0 responses
    15 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    68 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    48 views
    0 reactions
    Last Post SEQadmin2  
    Working...